Covaxin, made by Bharat Biotech, is now on the UK’s list of authorized Covid-19 vaccinations for overseas travellers.
A pre-departure PCR test or self-isolation at the address stated on their mandatory Passenger Locator Forms would be unnecessary for fully vaccinated Indians traveling to the UK.
They, like all fully vaccinated visitors, must pre-book a PCR or Lateral Flow Test upon arrival in England, to be taken by the end of day 2.
“The government will identify vaccinations on the WHO Emergency Use Listing (WHO EUL) at the border,” the UK Department for Transport stated.
In addition to Covaxin, the UK government has licenced vaccines from Sinovac and Sinopharm.
These three vaccinations have reportedly been provided in over one billion doses globally. The new adjustments were disclosed earlier this month, shortly after the WHO designated Covaxin as a “emergency-use listing” on November 3.
Several nations soon recognised the Indian vaccination. Covishield, another Indian vaccine, was cleared for entry on October 4. From October 11, India’s vaccination certifications were also recognised.